chrisvoncsefalvay/vaers-outcomes huggingface dataset:
grand mal seizures; absence seizures; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of GENERALISED TONIC-CLONIC SEIZURE (grand mal seizures) and PETIT MAL EPILEPSY (absence seizures) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Seizures (Patient had a history of seizures but had not had any since a very long time.).   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced GENERALISED TONIC-CLONIC SEIZURE (grand mal seizures) (seriousness criterion medically significant) and PETIT MAL EPILEPSY (absence seizures) (seriousness criterion medically significant). At the time of the report, GENERALISED TONIC-CLONIC SEIZURE (grand mal seizures) and PETIT MAL EPILEPSY (absence seizures) outcome was unknown. Not Provided          Concomitant medication use was not reported.  Treatment information was not reported.  The patient reported that he had a grand mal seizure approximately 8 hours after the first vaccine dose. Thereafter, the patient stated that he is now averaging 3 -4 seizures per week. The patient endorses that he has never had daytime seizures before.  The patient saw his neurologist who said there was no concern and advised that he continue to monitor.   The patient stated that he did receive his second dose of the vaccine, dates were not reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, patient's hx of seizure is a confounding factor that may play a possible contributory role.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However, patient's hx of seizure is a confounding factor that may play a possible contributory role.
Patient came to clinic today at 1530 and was examined. Pt had moderate edema (from top of the deltoid region to mid arm) and erythema in L deltoid region. Noted his arm felt itchy, but did not scratch. Parents reported highest temp was last night at 39 degrees Celsius (102.2 F). Parents gave him medicine and his fever came down. Current temp 99.8 degrees Fahrenheit. Last dose of medicine given around 1400. Parents were instructed to give him Tylenol and Benadryl, weight-based dosing was explained and handout was given. Parents were instructed if the swelling or redness spreads, impaired movement, or increasingly high temps that are not relieved by medicine, please return to clinic or call urgent care.
shingles; This spontaneous case was reported by a nurse and describes the occurrence of HERPES ZOSTER ( shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER ( shingles). At the time of the report, HERPES ZOSTER ( shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication were provided. No concomitant medication were provided.
multiple outbreaks of herpes zoster; Information has been received regarding a case in litigation from a lawyer regarding a patient of unknown gender and age. There was no information about the patient's concurrent conditions, medical history or concomitant medication.  On 18-OCT-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) for the long-term prevention of shingles and zoster-related conditions (dose, route of administration, lot number and expiration date were not reported).  On an unknown date, as the result of the use of zoster vaccine live (ZOSTAVAX), the patient presented multiple outbreaks of herpes zoster for which the patient was treated. The patient claimed damages, including injury to themselves, loss of consortium, loss of services, and economic losses. The outcome of the event was not provided.
hives; itchy; Sneezing; severe allergies; This is a spontaneous report from a contactable consumer, the patient. This 47-year-old patient of unspecified gender received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot: EW0179) via unspecified route in the left arm on 19May2021 at 14:00 (at the age of 47-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot: EW0778) via unspecified route in the left arm on 09Jun2021 at 14:00 (at the age of 47-years-old), both doses as single doses for COVID-19 immunization. Medical history included high blood pressure. The patient did not receive any vaccinations prior to the COVID vaccine. Concomitant medication included azilsartan medoxomil, chlortalidone (EDARBYCLOR) for high blood pressure. On an unspecified date in 2021, after the first vaccine, the patient broke out in hives they are mainly really itchy. Patient had to take diphenhydramine hcl (BENADRYL) and his/her doctor gave prednisone. Then a month later (2021) the same thing happened, patient got the hives again and got itchy all over again. It only happens on the same side and the same arm, that patient got the vaccine in. Patient reported he/she received it from the both doses of the vaccine, but the second one was worse than the first one. Patient stated got the regular Benadryl over the counter but the doctor has been prescribing prednisone (patient thinks it was 10 mg) for severe allergies to help with the itching and the sneezing. Patient only take its during that time when he/she had the hives and itching. The outcome of the events was unknown.  Follow-up attempts are completed. No further information is expected.
Have been sick since I got it; That shot came very close to killing me; pain in that lift arm; Still get really tired; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Have been sick since I got it), VACCINATION COMPLICATION (That shot came very close to killing me), MYALGIA (pain in that lift arm) and FATIGUE (Still get really tired) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ILLNESS (Have been sick since I got it), VACCINATION COMPLICATION (That shot came very close to killing me), MYALGIA (pain in that lift arm) and FATIGUE (Still get really tired). At the time of the report, ILLNESS (Have been sick since I got it), VACCINATION COMPLICATION (That shot came very close to killing me), MYALGIA (pain in that lift arm) and FATIGUE (Still get really tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were provided. No treatment details were provided.
High Fever, Irritability, Crying. Cooled with a damp cloth and gave child Tylenol. She vomited a lot shortly afterward, then fever subsided and slept soundly until morning. She vomited a small amount at 7:15 AM but no fever. Child appeared normal in behavior rest of the day and since. However, stools immediately were very loose and frequent and sometimes painful for about 8 days. Other 2 children and both parents also received flu vaccine with no symptoms nor illness.
stiffness; rash in left arm pit/under the left arm; Hearing was dull; disoriented for week; headache/pain in head, felt as if someone was hitting with a stick of wood and experiencing sore at the top of head; This is a spontaneous report from a contactable consumer (patient). A 72-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was EP7534), via an unspecified route of administration, in Left Arm on 23Mar2021 at 16:00 (at the age of 72-years-old) at single dose for COVID-19 immunization.  Medical history included asthma. Concomitant medications included Tamsulosin received within 2 weeks of vaccination. Patient had no allergies to medications, food or other products. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE ; lot number was EN6202) in Left Arm on 02Mar2021 at 16:00 (at the age of 72-years-old) at single dose for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination has not been tested for COVID-19. The patient experienced stiffness, rash in left arm pit/under the left arm and hearing was dull, experienced ringing in the left ear on 24Mar2021 at 12:00. Patient was disoriented on 24Mar2021 at 12:00 for a week. It was reported that patient experienced headache/pain in head, felt as if someone was hitting with a stick of wood and experiencing sore at the top of head from 24Mar2021 for two weeks. No treatment was given for the events. The outcome of the events was recovered.  No follow-up attempts are possible. No further information is expected.
Very tired for two days; A non stop headache; This is a spontaneous report from a contactable consumer (patient). A 42-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 11Jun2021 10:15 (Lot number: 59257-1000-1) as dose 2, single for covid-19 immunization at the age of 42-year-old. Medical history included attention deficit hyperactivity disorder from an unknown date and unknown if ongoing , depression from an unknown date and unknown if ongoing, and COVID-19 in Dec2020. The patient was non-pregnant. Concomitant medication included lisdexamfetamine mesilate (VYVANSE) taken for an unspecified indication, start and stop date were not reported; fluoxetine taken for an unspecified indication, start and stop date were not reported; zinc chloride taken for an unspecified indication, start and stop date were not reported; ascorbic acid (VIT-C) taken for an unspecified indication, start and stop date were not reported; iron taken for an unspecified indication, start and stop date were not reported; biotin taken for an unspecified indication, start and stop date were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in left arm on 20May2021 11:00 (Lot number: 59257-1000-1) as dose 1, single for covid-19 immunization at the age of 42-year-old. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that she still tested positive for antibodies in May2021 when she donated platelets. The patient reported that she felt very tired for two days. As of 13Jun2021 she had a non-stop headache and that it lasted all day (as reported). Patient stated that she never got headaches much before, maybe twice a year and that this was driving her crazy. Patient stated she took several ibuprofen (ADVIL) daily and nothing helped. Patient was still continuing to feel tired. The onset of the events was on 13Jun2021 10:00 (as reported). The outcome of the events was not reported.
Pt recv vax on 4/1/99; on 4/2/99 pt exp generalized urticaria
Beginning two days after the vaccination, dizziness, joint pain, difficulty falling asleep, difficulty concentrating, difficulty with balance.  Symptoms became less severe slowly over 2 months.  Currently, 6/10/21, symptoms are dizziness, difficulty concentrating, fatigue, stuffiness in left ear, and some difficulty falling asleep.    Below, you ask about disability. I don?t know yet.
Swollen lymph nodes, rash in face, neck, back and stomach. Malaise body ache, ears ringing, swollen face, arms, and hands with fever Tylenol for pain, Benadryl for rash and steroids for inflammation.
DID WELL AFTER RECEIVING VACCINE UNTIL 8 DAYS LATER WHEN INJECTION SITE BECAME RED, SWOLLEN, WARM AND PAINFUL
This case was reported by a nurse via call center representative and described the occurrence of injection site swelling in a female patient who received BOOSTRIX (batch number 3K44J, expiry date 17th October 2019). Concurrent medical conditions included sulfonamide allergy. Concomitant products included TAXOTERE. On 19th February 2018, the patient received BOOSTRIX. On an unknown date, the dose was an unknown dose. On 23rd February 2018, 4 days after receiving BOOSTRIX, the patient experienced injection site swelling, injection site erythema, injection site vesicles and rash. On an unknown date, the outcome of the injection site swelling, injection site erythema, injection site vesicles and rash were unknown. It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site vesicles and rash to be related to BOOSTRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that the patient was not pregnant. The reporter stated that the patient had a sulfa allergy. The patient received BOOSTRIX on left deltoid. The patient developed swelling, redness, and bleps or vesicles around the injection site. A blep or rash had also developed on the patient's wrist. The patient also had a PPD placed on the same arm as the BOOSTRIX. The reporter stated that the patient was currently on TAXOTERE. The reporter stated that the patient would go to occupational health for evaluation, and was not aware of any other medical intervention that had been taken.
I received a yearly influenza vaccine (with the H1N1 in it). I have been having involuntary muscle spasms since recieving the vaccine. They are located in my eyelids, my pectoral (chest) region, and upper extremeties (near armpit and shoulder).
10 min after shot patient felt dizzy, tired, hands shaky. Was unstable on her feet when she got up from the chair. On questioning reported that she didn't have anything to eat or drink this morning. Provided patient some candy and water, symptoms resolved by the time she left, 30 minutes after the shot.
16 hrs /p recving DTP/OPV pt c/o of headache.Mom reported projectile vomiting twice,pale,lethargic,nl T.
Coughing three weeks 24/7, joint pain severe, poor balance, fell-cut head in bathroom 4:30 AM, total mental confusion. Hospitalized. Severe pain all joints. Sensitive skin. Several trips to E.R. Blood work, X Rays, CAT scan. Scalp surgery (minor) pain still is worse.
Chickenpox like breakouts. Dermatologist diagnosed Lichen Planus as result of shingles vaccine. Within a few hrs. of shingles vaccine developed 101 degree fever for 2 days. Within 2 wks start to break out on chest with chickenpox type of pimples (no itch or pain). Tender to touch. Over several months it's gotten much worse. Dermatologist said I developed Lichen Planus from shot. (Have never had any auto immune disease of skin breakout before). Was told I could have it for 4 yrs and possibly for the remainder of my life. Have seen my primary care physician and another visit to his P.A. - all said it was from shingles shot. See photos - definitely herpes zoster blisters. Am permanently on Cortisone cream.
Week later got covid arm.  Rash, hard, hot and itchy and burning at site of injection
Post vax, pt suffered from repeated ear infections. He had diarrhea and sleep problems for several weeks after that and started to regress developmentally. 07/26/2000CB from mom w/answers to questions: MMR on 12/27/1993 was 1st one, had a 2nd at 4 1/2 yrs-reports high levels of mercury in urine perfectly. Awaiting blood results, was finishing a course of amoxicillin at time of first urine-not acutely ill: med Hx is (-) other than chronic OM: birth wt was 7lb 7oz, has a sister now age 14-she had herMMR's at 4 1/2 and 12 yrs, no AE's
? seizure-like episode > 48 hours, less than 72 hours following DAPT, HEP B-HIB, IPV, Pneumococcal, parents noted eyes rolling momentarily, then child was limp for few seconds before recovering completely.
pt recv vax 19JUN96 next day whelp surrounding inj site & knot under site;23JUn devel red ring around inj site, re-eval 24JUN & noted to have bruise @ inj site, central clearing & large erythemous rash surrounding inj site
Pt received first dose of COVID-19 vaccine on 5/8/21, pt later became ill with COVID19, presenting to ED for testing on 5/22/2021 but was not admitted at this time because symptoms were more mild and manageable at home.  Returned to ED on 5/26 and at this time was admitted for weakness and hypoxemia related to COVID pneumonia.  Discharged 6/1/2021
101.5 Fever, chills, nausea, vomiting, dizziness, headache, exhaustion/fatigue,
cold and cough; cold and cough; This is a spontaneous report from a contactable consumer or other non hcp consumer). A 26-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: Not reported) via an unspecified route of administration on an unspecified date as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. It was unknown whether the patient had covid prior vaccination. It was unknown whether the patient was tested Covid post vaccination. It was unknown whether the patient received other vaccine in four weeks, or he had received any other medications in two weeks. On an unspecified date, after vaccination the patient experienced cold, and cough and his second dose were due today. Consumer stated he did not have a fever. Consumer asked that it was ok for him to proceed with getting the second dose today. It was unknown if patient received any treatment for event. The outcome of the events was unknown.  No follow up attempts are needed. No further information is expected.
Second dose: 21 day after first dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose: 21 day after first dose) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In April 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In April 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose: 21 day after first dose). In April 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Second dose: 21 day after first dose) had resolved.            No concomitant medication were reported  No treatment information was reported   This case was linked to MOD-2022-448146, MOD-2022-447768 (Patient Link).
I experienced body aches and fatigue. I started having fever and congestion. My sinuses were running cray. I couldn't breath so I went to the doctor and they gave me a medication for Promethazine. It did not improve so I went back a week later because I had 103 fever. They told me to continue the medication and amoxicillin. Then I stopped taking the promethazine. I started taking the allergy tablet Claritin. The second visit to the doctor was on June 14th. I started improving. My hands were peeling profusely. I had a burning felling in them with blisters and they are still peeling but not as bad. I still have some congestion and fatigue. I don't have a fever. I had red dots all over my legs but those are clearing up.
Injection site - large red "egg" localized in right upper arm and very itchy appeared also hard on 5/1/14 - day after received vaccine. BENADRYL to treat started 5/2/2014.
pt recvd vax;mom called 345PM to report pt w/ n,couldn't move arm; pt assessed by 2 PHN's 415PM; t97.6 ax, pallor noted;nauseated w/emesis;2 hive-like circular lesions noted around rt inner arm near elbow;c/o abdo pain,adm for observation;
Strong chills, feverish beginning @ 6:30 p.m. and lasting until about 1:00 p.m. the following day.
Severe Vertigo. 3 days later still having it. Mornings are fine for first couple hours. Then on/off rest of day. Even with laying down and resting most of the time. Slight ringing in ears.
Information has been received from a registered nurse concerning a 13 year old Hispanic female who on 21-MAY-1999 was vaccinated SC in the right arm with a first dose of varicella virus vaccine live (Oka/Merck) (Lot#630027/0312J). Concomitant therapy included a second dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (MSD) (Lot#630104/0127J) given SC in the left arm. The patient was seen in the office on 17-MAY-2007 with a rash that started the previous week. She had scattered areas all over the body. She was diagnosed with chickenpox. Symptomatic treatment was prescribed. There was no fever or complications. No further information was provided. Additional information has been requested. This is one of several reports from the same source.
Patient reports feeling tired and numbness to her lips, no other symptom reported, patient reports numbness to her lips improved Patient was seen and cleared by EMS BP:158/77, pulse: 70, Spo2 100%
3/6 AM-onset of body aches and headache (improved with Naproxen), fell back asleep. Fatigued later that morning   3/6 Afternoon- body ache and fever (improved with Tylenol) 3/6 Evening- body aches and chills  3/7 AM symptoms resolved
Swelling in upper arm where injection occurred began within minutes. By second day swelling had extended to lymph nodes in armpit. By third day, swelling reduced but red splotches and discolouration was present on arm. By fourth day, all symptoms had ceased. Accompanied by body aches.
Fever, body aches, chills - onset 10 hours post injection and lasted 16 hours.   Fatigue - onset 2 hours post injection and lasted 36 hours Fever dreams  and night sweats during sleep same night. Sinus headache - onset following day (20 hours post injection) lasted 6-8 hours.
Mom reports twins got up thru night crying & were very hot to touch & very red color; t102, both twins cried for over 3hrs; Unable to console;  MD states should just receive DT;